Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine: 4 clinical trials tracked.
Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 2 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (4)
A Phase 1, Randomized, Double-Blind, Comparator-Controlled Dose-Escalation Study to Evaluate the Safety, Tolerability, and Immunogenicity of V132 in Healthy Older Participants
Primary endpoint: Percentage of Participants with Immediate Reactions Occurring Within 30 Minutes After Any Vaccination
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V118 Formulation E in Healthy Adults
Primary endpoint: Number of Participants With Solicited Injection-Site Adverse Events (AEs)
A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS
Primary endpoint: The proportion of maternal participants reporting prespecified local reactions within 7 days following study intervention
A Phase 1/2, Randomized, Observer-Blind, Dose-Finding, Active-Controlled, Parallel-Group, Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Healthy Adults Aged 50 Years and Older
Primary endpoint: Percentage of Subjects Reporting Solicited Local Reactions Within 7 Days After Vaccination (Redness, Swelling, and Pain at Injection Site) in Each Age Group